Ebola Vaccine From Glaxo Passes Early Trials
November 26, 2014 at 17:46 PM EST
A possible Ebola vaccine under development by GlaxoSmithKline PLC and various U.S. government health agencies has shown positive results in a phase-1 trial, according to findings published Wednesday.
